Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 7;19(1):321.
doi: 10.1186/s12891-018-2181-9.

The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials

Huazhang Xiong  1   2 , Yi Liu  2 , Yi Zeng  1 , Yuangang Wu  1 , Bin Shen  3
Affiliations
Review

The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials

Huazhang Xiong et al. BMC Musculoskelet Disord. .

Abstract

Background: The combined administration of intravenous (IV) and topical tranexamic acid (TXA) in primary total knee (TKA) knee remains controversial. The purpose of this meta-analysis was to assess the efficacy and safety of combined administration of IV and topical TXA in primary TKA.

Methods: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, Google Search Engine and China National Knowledge Infrastructure databases were searched for randomized controlled trials (RCTs) were comparing the combined administration of IV and topical TXA following primary TKA. The primary outcomes were total blood loss, maximum hemoglobin drop, and deep venous thrombosis (DVT) and/or pulmonary embolism (PE). The second outcomes were drainage volume and transfusion requirements. Data were analyzed using RevMan 5.3.

Results: A total of 6 RCTs involving 701 patients were included in the meta-analysis. The combined group provided lower total blood loss (MD - 156.34 mL, 95% CI, - 241.51 to - 71.18; P = 0.0003), drainage volume (MD - 43.54 mL, 95% CI, - 67.59 to - 19.48; P = 0.0004), maximum hemoglobin drop (MD - 0.56 g/dl, 95% CI, - 0.93 to - 0.19; P = 0.003) than IV TXA alone. No significant difference were found in terms of transfusion requirements (RR 0.48, 95% CI, 0.16 to 1.44; P = 0.19), DVT (RR 1.01, 95% CI, 0.14 to 7.12; P = 0.99) and PE (RR 0.33, 95% CI, 0.01 to 7.91; P = 0.49) between the two group. Subgroup analyses shows that the combined group was less total blood loss in non-tourniquet (P = 0.0008), topical TXA dose > 1.5 g (P < 0.00001) and number of IV TXA ≥ 2 doses (P = 0.005) of TXA compared with the IV group alone.

Conclusions: The available evidence indicates combined group were associated with lower total blood loss, drainage volume, and maximum hemoglobin drop. A similar transfusion requirement was found in both groups. Subgroup analyses demonstrates that total blood loss was less in patients with non-tourniquet, topical TXA dose > 1.5 g and number of IV TXA ≥ 2 doses of TXA. There was no increase the rates of DVT and PE.

Keywords: Blood loss; Intravenous; Topical; Total knee arthroplasty; Tranexamic acid.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Ethical approval is not necessary because it is a comment on previously published articles and does not involve the handling of any personal patient data.

Consent for publication

All authors agree to publish.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flow chart of inclusion and exclusion for eligible studies
Fig. 2
Fig. 2
Funnel plot of total blood loss (a), drainage volume (b), maximum hemoglobin drop (c), transfusion requirements (d), and DVT (e)
Fig. 3
Fig. 3
Forest plot analysis of total blood loss
Fig. 4
Fig. 4
Forest plot analysis of drainage volume
Fig. 5
Fig. 5
Forest plot analysis of maximum hemoglobin drop
Fig. 6
Fig. 6
Forest plot analysis of transfusion requirements
Fig. 7
Fig. 7
Forest plot analysis of DVT
See this image and copyright information in PMC

References

    1. Zeni JA, Jr, Axe MJ, Snyder-Mackler L. Clinical predictors of elective total joint replacement in persons with end-stage knee osteoarthritis. BMC Musculoskelet Disord. 2010;11:86. doi: 10.1186/1471-2474-11-86. - DOI - PMC - PubMed
    1. Levine BR, Haughom B, Strong B, Hellman M, Frank RM. Blood management strategies for total knee arthroplasty. J Am Acad Orthop Surg. 2014;22:361–371. doi: 10.5435/JAAOS-22-06-361. - DOI - PubMed
    1. Edelstein AI, Kwasny MJ, Suleiman LI, Khakhkhar RH, Moore MA, Beal MD, et al. Can the American College of Surgeons risk calculator predict 30-day complications after knee and hip arthroplasty? J Arthroplast 2015;30:5–10. - PubMed
    1. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.J Bone Joint Surg Am 2010 ;92:2503–2513. - PubMed
    1. Chen JY, Chin PL, Moo IH, Pang HN, Tay DK, Chia SL, et al. Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: a double-blinded randomised controlled noninferiority trial. Knee. 2016;23:152–156. doi: 10.1016/j.knee.2015.09.004. - DOI - PubMed

MeSH terms